Skip to main content

MDMA

ADVERTISEMENT
Identification
Molecular formula
C11H15NO2
CAS number
22204-42-4
IUPAC name
3-(3,4-dihydro-1H-isoquinolin-2-yl)-2-methyl-1,1-diphenyl-propan-1-ol
State
State

At room temperature, MDMA is typically in a crystalline solid form. It can be formulated into powder or tablet forms for consumption. Due to its hygroscopic nature, it may clump together when exposed to moisture.

Melting point (Celsius)
147.50
Melting point (Kelvin)
420.65
Boiling point (Celsius)
245.40
Boiling point (Kelvin)
518.55
General information
Molecular weight
193.27g/mol
Molar mass
193.2670g/mol
Density
1.1101g/cm3
Appearence

MDMA, commonly known as ecstasy, appears as a white or off-white powder or crystalline material. It is sometimes pressed into tablets or capsules with various colors and logos. In pure form, it may be slightly yellowish, and it is hygroscopic in nature, absorbing moisture from the air.

Comment on solubility

Solubility of 3-(3,4-dihydro-1H-isoquinolin-2-yl)-2-methyl-1,1-diphenyl-propan-1-ol

The solubility of 3-(3,4-dihydro-1H-isoquinolin-2-yl)-2-methyl-1,1-diphenyl-propan-1-ol can be characterized by several key factors:

  • Polarity: This compound contains multiple aromatic groups and a hydroxyl functional group, which can influence its interaction with polar and non-polar solvents.
  • Solvent Interaction: Typically, due to the presence of the hydroxyl group, this compound may exhibit solubility in polar solvents such as methanol and ethanol.
  • Hydrogen Bonding: The hydroxyl group may engage in hydrogen bonding, which can enhance solubility in water but is likely lower when compared to small, less complex solutes.
  • Substituents Impact: The bulky diphenyl and isoquinoline groups could hinder solubility in less polar solvents, suggesting limited miscibility.

In conclusion, while the compound may demonstrate some solubility in polar environments, its complex structure indicates that successful dissolution will depend heavily on the solvent choice as well as temperature and concentration factors. Understanding the solubility profile is crucial for its applications in various chemical processes.

Interesting facts

Interesting Facts about 3-(3,4-dihydro-1H-isoquinolin-2-yl)-2-methyl-1,1-diphenyl-propan-1-ol

The compound known as 3-(3,4-dihydro-1H-isoquinolin-2-yl)-2-methyl-1,1-diphenyl-propan-1-ol stands out for its structural complexity and potential applications in medicinal chemistry. Here are some intriguing aspects of this compound:

  • Diverse Applications: This compound may play a role in various therapeutic areas, particularly due to its isoquinoline structure, which is often associated with biological activity.
  • Isoquinoline Derivatives: Compounds that contain the isoquinoline motif are well-researched for their wide array of pharmacological properties, including antitumor, anti-inflammatory, and analgesic activities.
  • Chirality and Stereochemistry: The presence of multiple chiral centers in this compound can lead to the formation of enantiomers, which may exhibit significantly different biological activities. This underscores the importance of stereochemistry in drug development.
  • Research Potential: Its unique structure invites further exploration into its interactions within biological systems, potentially leading to new discoveries in drug efficacy and safety.
  • Analogous Compounds: Investigating analogs of this molecule can provide insights into structure-activity relationships, giving researchers a pathway to optimize similar compounds for enhanced therapeutic effects.

Due to its intricate design, 3-(3,4-dihydro-1H-isoquinolin-2-yl)-2-methyl-1,1-diphenyl-propan-1-ol is a fascinating target for continued research and development in the field of organic chemistry and pharmacology. As scientists delve deeper into its properties, there may be exciting developments on the horizon.

Synonyms
3,4-Dihydro-alpha,alpha-diphenyl-beta-methyl-2(1H)-isoquinolinepropanol
3518-97-6
BRN 1438747
2(1H)-ISOQUINOLINEPROPANOL, 3,4-DIHYDRO-alpha,alpha-DIPHENYL-beta-METHYL-
2-(3,3-Diphenyl-3-hydroxy-2-methylpropyl)-1,2,3,4-tetrahydroisoquinoline
5-20-06-00328 (Beilstein Handbook Reference)
DTXSID70956626
3-(3,4-Dihydroisoquinolin-2(1H)-yl)-2-methyl-1,1-diphenylpropan-1-ol